By using the Coons indirect immunofluorescence technique, enkephalin-like immunoreactivity with a granular localization was observed in human adrenal medullary gland cells and pheochromocytomas. In two of the tumors and in a few adrenal gland cells, a somatostatin-like peptide could also be identified. Catecholamine cell types were visualized on adjacent sections with antisera to the synthesizing enzymes dopamine-,-hydroxylase [DBH; dopamine ,-monooxygenase; 3,4-dihydroxyphenylethylamine,ascorbate:oxygen oxidoreductase (-hydoxyating), EC 1.14.17.1] and phenylethanolamine-N-methyltransferase (PNMT; noradrenalin N-methyltransferase; S-adenosyl-L-methionine:phenylethanolamine N-methyltransferase, EC 2.1.1.28). In the normal adrenal medulla more DBH-than PNMT-immunoreactive land cells were observed. In the adrenal pheochromocytoma both DBH-and PNMT-positive cells were seen, whereas the two extra-adrenal tumors contained only DBH. These findings correlated well with plasma catecholamine measurements. Finally, enkephalin immunoreactive fibers and somatostatin immunoreactive cells were observed in a sympathetic ganglion extirpated together with one of the tumors.
Endogenous ligands to the opiate receptors have been discovered (1) (2) (3) (4) (5) (6) (7) . With antisera raised to such ligands, the enkephalins and the endorphins, it has been possible to localize these peptides in the nervous system of experimental animals by using immunocytochemistry. General agreement seems to exist that, whereas the f3-endorphin system has a restricted distribution with cell bodies only in the hypothalamus (8, 9) , the enkephalin neurons are widely distributed in the brain, spinal cord (8) (9) (10) (11) (12) (13) (14) , and gastrointestinal tract (10, (15) (16) (17) . Recently, an enkephalin-like peptide has been observed in sympathetic ganglia (18) (19) (20) (21) and in many gland cells as well as in nerve fibers in the adrenal medulla of rat, guinea pig, and cat (19, 22) . Somatostatin (23) has been observed in endocrine cells and in the central and peripheral nervous system (24) , including sympathetic noradrenergic ganglion cells (25) .
In this paper we demonstrate that both an enkephalin-like and a somatostatin-like peptide are present in the human adrenal medulla as well as in human pheochromocytomas.
MATERIAL AND METHODS
Five human adrenal glands and three pheochromocytomas obtained from humans at surgery and one human post-mortem gland were studied (Table 1) . Of these glands, three were obtained from patients with widespread metastases from mammary carcinoma. They All patients with pheochromocytoma were pretreated for about 14 days with the a-receptor blocking drug phenoxybenzamine in increasing dosage.
Catecholamines were determined in plasma before and during operation by using high-pressure liquid chromatography with electrochemical detection (26) .
The present study was approved by the Ethical Committee at the Karolinska Hospital.
Immediately after extirpation, the glands were sliced (about 5 mm thick) and immersed for 4-72 hr in ice-cold 10% (wt/vol) formalin in 0.1 M sodium phosphate buffer (27) . After rinsing in 0.1 M phosphate buffer with 5% sucrose for at least 24 (21, 25) . Normal rabbit antiserum was used as control for the antisera to the catecholamine-synthesizing enzymes.
[Met]Enkephalin and a-and f3-endorphin were purchased from Peninsula Laboratories (San Carlos, CA), and [Leujenkephalin was generously donated by L. Stein (Wyeth). Somatostatin was generously given by KABI (Stockholm, Sweden).
The immunohistochemistry was carried out according to the indirect procedure of Coons (32) , as described (33) . The incubations were performed in a humid atmosphere for at least 16 hr at 40C and were followed by rinsing in phosphate-buffered saline, incubation for 30 min at 370C with sheep anti-rabbit fluorescein-isothiocyanate-conjugated antibodies (SBL, Stockholm, Sweden) diluted 1:4, and then rinsing and mounting in phosphate-buffered saline/glycerol (1:3, vol/vol). All antisera contained 0.3% Triton X-100 (34) . The sections were examined Abbreviations: DBH, dopamine f3-hydroxylase; PNMT, phenylethanolamine N-methyltransferase.
(opioid in a Zeiss fluorescence microscope (21) . Scopix RP1 (Gevaert, Belgium) and Kodak Ektachrome high speed films were used. Table 1 presents the patient material and most of the results obtained. The normal plasma levels of norepinephrine and epinephrine are <5 nM and <1 nM, respectively. It may be added that, during surgical manipulation of the tumor of pheochromocytoma patient A (male, 73 years old), norepinephrine and epinephrine increased to up to 3000 nM.
RESULTS
In patient B (female, 51 years old), an extra-adrenal pheochromocytoma was found close to the lumbar sympathetic chain infiltrating the aortic wall; in patient C (male, 39 years old), a pheochromocytoma was found in the wall of the urinary bladder. Preoperative plasma norepinephrine in the latter increased after micturation from normal up to 250 nM. For further details on plasm catecholamines and pheochromocytoma, see ref. 35.11 In the adrenal glands, the immunohistochemical analyses revealed strong [Met] (Fig. 1 a-c) . No specific fluorescence was observed after incubation with antisera to a-and f3-endorphin. On adjacent sections probably all gland cells were DBH immunoreactive (Fig. lb) . PNMT immunoreactivity was also seen in most gland cells (Fig. lc) 2g ) and a few somatostatin-immunoreactive neurons among the principal ganglion cells. The cells of this pheochromocytoma were lying in strings growing diffusely into the surrounding tissues. They were smaller than those in tumor A, often demonstrating short processes and mostly containing
[Met]enkephalin-like immunoreactivity (Fig. 2h) (Fig. 2i) but none was PNMT-immunoreactive (Fig. 2j) . In addition, some cells contained a somatostatin-like peptide.
The urinary bladder pheochromocytoma (C) demonstrated [Metlenkephalin but no other opioid peptide immunoreactivity (Fig. 2k) . The cells were DBH, but not PNMT, immunoreactive. Many cells were somatostatin immunoreactive. They were less numerous than the enkephalin-immunoreactive ones and often formed distinct groups (Fig. 21) . Adjacent sections revealed that the two peptides probably occurred together in some cells (Fig. 2 k and l) .
None of the immunofluorescent structures described above were observed on incubation with control sera of various types (Fig. 2 b and d) . This confirms the previous finding of enkephalin in peripheral neuroendocrine tumors (36) and our earlier observations on adrenal glands of experimental animals (19, 22) .
In three of the six glands, the enkephalin-immunoreactive cells represented a major proportion of the total number of gland cells, whereas only a few cells of the remaining glands contained this immunoreactivity. The reasons for this difference is not clear. The tissues might have been in different conditions at surgery, depending, e.g., on hypoxia or manipulation or preoperative drug treatment. Thus, only the three patients with low numbers of enkephalin-immunoreactive cells had been treated preoperatively for long periods with cytostatic drugs, high doses of corticosteroids, and analgesics of the morphine type.
In this connection, it is of interest that marked differences in the proportion of immunoreactive cells have been observed in other species. Thus, high proportions of enkephalin-immunoreactive cells were found in adrenals of untreated cats and guinea pigs but only a few in the adrenals of rats. However, even the rat adrenal medulla became rich in enkephalinimmunoreactive cells after sectioning of the greater splanchnic nerve (22 (21) . In agreement with their result, no a-or f3-endorphin-immunoreactive cells were observed either in the present study or in a previous study (22) . We cannot exclude that at least part of the immunoreactive material seen in the human adrenal medulla and in the pheochromocytomas is related to such a crossreacting peptide. At present, the possible physiological significance of an opioid peptide in the adrenal gland is not clear. It is noteworthy that enkephalin was present in the adrenal glands of all species so far studied [frog, chicken, rat, guinea pig, cat, dog, cow, and monkey (22, 37) ]. The enkephalin-like peptide may act intracellularly-e.g., on release mechanisms or in other intracellular regulatory events. Or it may be released and act on "autoreceptors" on the gland cells themselves. It may act on nerve endings at the gland cells or it may be released into the bloodstream (22 In the normal adrenal medulla, all cells were DBH-positive and most cells were PNMT-positive. This agrees with the fact that 10-20% of these cells contain norepinephrine whereas the remainder contain epinephrine (38) .
One pheochromocytoma (A) secreted both norepinephrine and epinephrine, which agrees with the histochemical finding of both DBH-and PNMT-positive cells. The other two secreted only norepinephrine and, consequently, contained only DBH-positive cells. However, it is worth emphasizing that, although pheochromocytes contain catecholamines (39), many cells were observed that lacked DBH. This may be attributed to a low crossreactivity between the DBH and PNMT in the human tumor cells and the antisera raised against bovine enzymes.
In conclusion, the present study indicates that human adrenal medullary cells and tumors of this cell type have the capacity to produce, store, and possibly release biologically active peptides, in addition to the classical secretory products norepinephrine and epinephrine. Thus, the adrenal medulla also constitutes a part of the amine precursor uptake and decarboxylation (APUD) system, as defined by Pearse (40 
